Ilona Hauber

2.6k total citations
51 papers, 2.0k citations indexed

About

Ilona Hauber is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Ilona Hauber has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Virology and 20 papers in Immunology. Recurrent topics in Ilona Hauber's work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (17 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Ilona Hauber is often cited by papers focused on HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (17 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Ilona Hauber collaborates with scholars based in Germany, Austria and United States. Ilona Hauber's co-authors include Joachim Hauber, Frank Buchholz, Michael B. Fischer, Indrani Sarkar, M Eibl, Boris Fehse, Barbara Holstermann, Heinrich Hohenberg, Jochen Heukeshoven and Vojtěch Thon and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ilona Hauber

50 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilona Hauber Germany 26 1.0k 609 404 352 247 51 2.0k
Bo Peng China 26 834 0.8× 638 1.0× 435 1.1× 307 0.9× 221 0.9× 103 2.4k
Thierry Idziorek France 23 829 0.8× 917 1.5× 646 1.6× 153 0.4× 290 1.2× 53 2.3k
Judy A. Mikovits United States 25 843 0.8× 866 1.4× 434 1.1× 117 0.3× 285 1.2× 51 2.2k
Liang Deng United States 27 823 0.8× 935 1.5× 307 0.8× 242 0.7× 432 1.7× 79 2.2k
Stephen Su United States 18 1.0k 1.0× 469 0.8× 148 0.4× 271 0.8× 329 1.3× 26 1.9k
Gregory A. Viglianti United States 24 813 0.8× 1.9k 3.1× 550 1.4× 161 0.5× 287 1.2× 42 3.0k
Hiroo Hoshino Japan 29 746 0.7× 868 1.4× 647 1.6× 138 0.4× 458 1.9× 99 2.3k
Joseph A. Hollenbaugh United States 21 699 0.7× 975 1.6× 647 1.6× 120 0.3× 455 1.8× 31 2.1k
Aldar S. Bourinbaiar United States 20 376 0.4× 573 0.9× 435 1.1× 141 0.4× 452 1.8× 72 1.6k
Maria Isaguliants Russia 21 719 0.7× 501 0.8× 401 1.0× 101 0.3× 292 1.2× 90 1.9k

Countries citing papers authored by Ilona Hauber

Since Specialization
Citations

This map shows the geographic impact of Ilona Hauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Hauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Hauber more than expected).

Fields of papers citing papers by Ilona Hauber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilona Hauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Hauber. The network helps show where Ilona Hauber may publish in the future.

Co-authorship network of co-authors of Ilona Hauber

This figure shows the co-authorship network connecting the top 25 collaborators of Ilona Hauber. A scholar is included among the top collaborators of Ilona Hauber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilona Hauber. Ilona Hauber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauber, Ilona, Ulrike C. Lange, Bjoern Traenkle, et al.. (2021). Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors. PLoS ONE. 16(12). e0261269–e0261269. 20 indexed citations
2.
Hauber, Ilona, et al.. (2018). Improving Lentiviral Transduction of CD34 + Hematopoietic Stem and Progenitor Cells. Human Gene Therapy Methods. 29(2). 104–113. 29 indexed citations
3.
Hauber, Ilona, Jan Chemnitz, Carola Schäfer, et al.. (2016). Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nature Biotechnology. 34(4). 401–409. 95 indexed citations
4.
Mock, Ulrike, Ilona Hauber, & Boris Fehse. (2016). Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases. Nature Protocols. 11(3). 598–615. 57 indexed citations
5.
Geißler, René, Ilona Hauber, Jan Chemnitz, et al.. (2015). Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study. Virology. 486. 248–254. 5 indexed citations
6.
Thierry, Sylvain, Ludivine Sinzelle, Christina Calmels, et al.. (2015). Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chemistry & Biology. 22(6). 712–723. 9 indexed citations
7.
Cosgun, Kadriye Nehir, Susann Rahmig, Nicole Mende, et al.. (2014). Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier. Cell stem cell. 15(2). 227–238. 121 indexed citations
8.
Hauber, Ilona, Jan Chemnitz, Janet Chusainow, et al.. (2013). Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice. PLoS Pathogens. 9(9). e1003587–e1003587. 47 indexed citations
9.
Hauber, Ilona, Ana Lilia Martínez-Rocha, Christian A. Voigt, et al.. (2011). Preventing Fusarium Head Blight of Wheat and Cob Rot of Maize by Inhibition of Fungal Deoxyhypusine Synthase. Molecular Plant-Microbe Interactions. 24(5). 619–627. 13 indexed citations
10.
Chemnitz, Jan, Nadine M. Turza, Ilona Hauber, Alexander Steinkasserer, & Joachim Hauber. (2009). The karyopherin CRM1 is required for dendritic cell maturation. Immunobiology. 215(5). 370–379. 10 indexed citations
11.
Schäfer, Birgit, et al.. (2006). Inhibition of Multidrug‐Resistant HIV‐1 by Interference with Cellular S‐adenosylmethionine Decarboxylase Activity. The Journal of Infectious Diseases. 194(6). 740–750. 20 indexed citations
12.
Heukeshoven, Jochen, Ilona Hauber, Carol Stocking, et al.. (2006). Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its Influence on CD83 Expression. Journal of Biological Chemistry. 282(7). 4504–4515. 54 indexed citations
13.
Hauber, Ilona, Dorian Bevec, Jochen Heukeshoven, et al.. (2005). Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. Journal of Clinical Investigation. 115(1). 76–85. 71 indexed citations
14.
Efferth, Thomas, Manfred Marschall, Xin Wang, et al.. (2001). Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. Journal of Molecular Medicine. 80(4). 233–242. 149 indexed citations
15.
Salzberger, Bernd, et al.. (2000). Occupational HIV infection documented by sequence analysis of source and index virus strains. HIV Medicine. 1(4). 256–258. 3 indexed citations
16.
Douhan, John, Ilona Hauber, Martha M. Eibl, & Laurie H. Glimcher. (1996). Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.. The Journal of Experimental Medicine. 183(3). 1063–1069. 29 indexed citations
17.
18.
Fischer, Michael B., Ilona Hauber, Vojtěch Thon, et al.. (1994). A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood. 84(12). 4234–4241. 82 indexed citations
19.
Fischer, Michael B., et al.. (1994). Impaired TCR signal transduction, but normal antigen presentation, in a patient with common variable immunodeficiency. British Journal of Haematology. 88(3). 520–526. 19 indexed citations
20.
Hauber, Ilona, et al.. (1993). Patients with common variable immunodeficiency (CVID) display aberrant IL-2 and IFN-gamma mRNA levels.. PubMed. 4(1-4). 25–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Peng Breakdown of academic impact, for papers by Thierry Idziorek Breakdown of academic impact, for papers by Judy A. Mikovits Breakdown of academic impact, for papers by Liang Deng Breakdown of academic impact, for papers by Stephen Su Breakdown of academic impact, for papers by Gregory A. Viglianti Breakdown of academic impact, for papers by Hiroo Hoshino Breakdown of academic impact, for papers by Joseph A. Hollenbaugh Breakdown of academic impact, for papers by Aldar S. Bourinbaiar Breakdown of academic impact, for papers by Maria Isaguliants
Rankless by CCL
2026